• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OSW-1,一种靶向 OSBP 的天然化合物,广谱抑制肠道病毒复制。

Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP.

机构信息

Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Department of Medical Microbiology, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Antiviral Res. 2015 May;117:110-4. doi: 10.1016/j.antiviral.2015.02.013. Epub 2015 Mar 6.

DOI:10.1016/j.antiviral.2015.02.013
PMID:25752737
Abstract

Enteroviruses, e.g., polio-, coxsackie- and rhinoviruses, constitute a large genus within the Picornaviridae family of positive-strand RNA viruses and include many important pathogens linked to a variety of acute and chronic diseases. Despite their huge medical and economic impact, no approved antiviral therapy is yet available. Recently, the oxysterol-binding protein (OSBP) was implicated as a host factor for enterovirus replication. Here, we investigated the antiviral activity of the natural compound OSW-1, a ligand of OSBP that is under investigation as an anti-cancer drug. OSW-1 potently inhibited the replication of all enteroviruses tested, with IC50 values in the low nanomolar range, acted at the genome replication stage and was effective in all tested cell types of three different species. Importantly, OSBP overexpression rescued viral replication, demonstrating that the antiviral effect of OSW-1 is due to targeting OSBP. Together, we here report the anti-enterovirus activity of the natural anti-cancer compound OSW-1.

摘要

肠道病毒,例如脊髓灰质炎病毒、柯萨奇病毒和鼻病毒,构成了正链 RNA 病毒小核糖核酸病毒科中的一个大属,包含许多与多种急性和慢性疾病相关的重要病原体。尽管它们具有巨大的医学和经济影响,但目前尚无批准的抗病毒疗法。最近,氧化固醇结合蛋白(OSBP)被认为是肠道病毒复制的宿主因子。在这里,我们研究了天然化合物 OSW-1 的抗病毒活性,OSW-1 是 OSBP 的配体,作为一种抗癌药物正在研究中。OSW-1 能够强烈抑制所有测试的肠道病毒的复制,其半数抑制浓度(IC50)值处于纳摩尔低水平,作用于基因组复制阶段,在三种不同物种的所有测试细胞类型中均有效。重要的是,OSBP 的过表达挽救了病毒复制,表明 OSW-1 的抗病毒作用是由于靶向 OSBP。总之,我们在这里报告了天然抗癌化合物 OSW-1 的抗肠道病毒活性。

相似文献

1
Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP.OSW-1,一种靶向 OSBP 的天然化合物,广谱抑制肠道病毒复制。
Antiviral Res. 2015 May;117:110-4. doi: 10.1016/j.antiviral.2015.02.013. Epub 2015 Mar 6.
2
Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307.发现氧化甾醇结合蛋白(OSBP)作为抗肠道病毒化合物TTP-8307的靶点。
Antiviral Res. 2017 Apr;140:37-44. doi: 10.1016/j.antiviral.2017.01.008. Epub 2017 Jan 11.
3
Differing activities of oxysterol-binding protein (OSBP) targeting anti-viral compounds.不同的固醇结合蛋白 (OSBP) 靶向抗病毒化合物的活性。
Antiviral Res. 2019 Oct;170:104548. doi: 10.1016/j.antiviral.2019.104548. Epub 2019 Jul 2.
4
Transient Compound Treatment Induces a Multigenerational Reduction of Oxysterol-Binding Protein (OSBP) Levels and Prophylactic Antiviral Activity.瞬时化合物处理诱导氧化固醇结合蛋白(OSBP)水平的多代减少和预防性抗病毒活性。
ACS Chem Biol. 2019 Feb 15;14(2):276-287. doi: 10.1021/acschembio.8b00984. Epub 2019 Jan 11.
5
Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein.伊曲康唑通过靶向氧化甾醇结合蛋白来抑制肠道病毒复制。
Cell Rep. 2015 Feb 3;10(4):600-15. doi: 10.1016/j.celrep.2014.12.054. Epub 2015 Jan 29.
6
Combating enterovirus replication: state-of-the-art on antiviral research.抗病毒研究的最新进展:对抗肠道病毒复制。
Biochem Pharmacol. 2012 Jan 15;83(2):185-92. doi: 10.1016/j.bcp.2011.08.016. Epub 2011 Aug 26.
7
Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP).依曲康唑的构效关系研究,一种广谱抑制微小核糖核酸病毒复制的药物,靶点为氧化固醇结合蛋白(OSBP)。
Antiviral Res. 2018 Aug;156:55-63. doi: 10.1016/j.antiviral.2018.05.010. Epub 2018 May 26.
8
Modulation of proteolytic polyprotein processing by coxsackievirus mutants resistant to inhibitors targeting phosphatidylinositol-4-kinase IIIβ or oxysterol binding protein.柯萨奇病毒突变体对针对磷脂酰肌醇-4-激酶 IIIβ或氧化固醇结合蛋白的抑制剂的抗性对蛋白水解多蛋白加工的调节。
Antiviral Res. 2017 Nov;147:86-90. doi: 10.1016/j.antiviral.2017.10.006. Epub 2017 Oct 9.
9
Antiviral activity of substituted homoisoflavonoids on enteroviruses.取代高异黄酮对肠道病毒的抗病毒活性。
Antiviral Res. 2006 Dec;72(3):252-5. doi: 10.1016/j.antiviral.2006.07.003. Epub 2006 Jul 28.
10
Mutations in Encephalomyocarditis Virus 3A Protein Uncouple the Dependency of Genome Replication on Host Factors Phosphatidylinositol 4-Kinase IIIα and Oxysterol-Binding Protein.脑心肌炎病毒3A蛋白的突变解除了基因组复制对宿主因子磷脂酰肌醇4激酶IIIα和氧化甾醇结合蛋白的依赖性。
mSphere. 2016 May 11;1(3). doi: 10.1128/mSphere.00068-16. eCollection 2016 May-Jun.

引用本文的文献

1
Anti-SARS-CoV-2 Small Molecule Targeting of Oxysterol-Binding Protein (OSBP) Activates Cellular Antiviral Innate Immunity.靶向氧化甾醇结合蛋白(OSBP)的抗严重急性呼吸综合征冠状病毒2(SARS-CoV-2)小分子激活细胞抗病毒固有免疫。
ACS Infect Dis. 2025 May 9;11(5):1064-1077. doi: 10.1021/acsinfecdis.4c00631. Epub 2025 Apr 21.
2
Oxysterole-binding protein targeted by SARS-CoV-2 viral proteins regulates coronavirus replication.SARS-CoV-2 病毒蛋白靶向的氧化固醇结合蛋白调节冠状病毒复制。
Front Cell Infect Microbiol. 2024 Jul 25;14:1383917. doi: 10.3389/fcimb.2024.1383917. eCollection 2024.
3
Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents.
植物源表生营养物作为广谱抗病毒药物的潜力
Nutrients. 2023 Nov 8;15(22):4719. doi: 10.3390/nu15224719.
4
Organelles are miscommunicating: Membrane contact sites getting hijacked by pathogens.细胞器在“交流失误”:病原体劫持膜接触位点。
Virulence. 2023 Dec;14(1):2265095. doi: 10.1080/21505594.2023.2265095. Epub 2023 Oct 20.
5
Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances.针对肠道病毒B感染的直接作用抗病毒药物和宿主靶向方法:最新进展
Pharmaceuticals (Basel). 2023 Jan 29;16(2):203. doi: 10.3390/ph16020203.
6
Structure-Activity Relationships of Ligand Binding to Oxysterol-Binding Protein (OSBP) and OSBP-Related Protein 4.配体与氧化固醇结合蛋白(OSBP)及其相关蛋白 4 结合的结构-活性关系。
J Med Chem. 2023 Mar 23;66(6):3866-3875. doi: 10.1021/acs.jmedchem.2c01025. Epub 2023 Mar 14.
7
Enterovirus A71 antivirals: Past, present, and future.肠道病毒A71抗病毒药物:过去、现在与未来。
Acta Pharm Sin B. 2022 Apr;12(4):1542-1566. doi: 10.1016/j.apsb.2021.08.017. Epub 2021 Aug 20.
8
Natural Ligand-Mimetic and Nonmimetic Inhibitors of the Ceramide Transport Protein CERT.天然配体模拟物和非模拟物抑制剂的神经酰胺转运蛋白 CERT。
Int J Mol Sci. 2022 Feb 14;23(4):2098. doi: 10.3390/ijms23042098.
9
Anticancer Effects and Mechanisms of OSW-1 Isolated From : A Review.从[来源]中分离得到的OSW-1的抗癌作用及机制:综述
Front Oncol. 2021 Sep 23;11:747718. doi: 10.3389/fonc.2021.747718. eCollection 2021.
10
Targeting Some Enzymes with Repurposing Approved Pharmaceutical Drugs for Expeditious Antiviral Approaches Against Newer Strains of COVID-19.针对某些酶,重新利用已批准的药物,为针对新型 COVID-19 病毒株的快速抗病毒方法提供支持。
AAPS PharmSciTech. 2021 Aug 10;22(6):214. doi: 10.1208/s12249-021-02089-5.